Nya feta intressanta studier:
https://www.biorxiv.org/content/10.1101/2021.08.03.454981v3
The emergence of highly fit SARS-CoV-2 variants accelerated by epistasis and caused by recombination
https://www.biorxiv.org/content/10.1101/2021.08.23.457408v1
Deep immune profiling of the maternal-fetal interface with mild SARS-CoV-2 infection
https://www.biorxiv.org/content/10.1101/2021.08.22.457114v1
The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines
https://www.medrxiv.org/content/10.1101/2021.08.19.21262307v1
Evolutionary dynamics of a virus in a vaccinated population
https://www.medrxiv.org/content/10.1101/2021.08.29.21262799v1
The emergence of SARS-CoV-2 variants of concern is driven by acceleration of the evolutionary rate
https://www.medrxiv.org/content/10.1101/2021.08.25.21262601v1
The resurgence risk of COVID-19 in the presence of immunity waning and ADE effect: a mathematical modelling study
https://www.biorxiv.org/content/10.1101/2021.08.10.455737v2
Spike mimicry of thrombopoietin may induce thrombocytopenia in COVID-19
https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1
SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database Analysis
https://www.biorxiv.org/content/10.1101/2021.09.06.459005v1
Ineffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera
https://www.medrxiv.org/content/10.1101/2021.09.03.21262934v1
Association Between SARS-CoV-2 RNAemia and Post-Acute Sequelae of COVID-19
https://www.biorxiv.org/content/10.1101/2021.06.01.446592v2
Multilocus adaptation to vaccination
https://www.biorxiv.org/content/10.1101/2021.08.03.454981v3
The emergence of highly fit SARS-CoV-2 variants accelerated by epistasis and caused by recombination
https://www.biorxiv.org/content/10.1101/2021.08.23.457408v1
Deep immune profiling of the maternal-fetal interface with mild SARS-CoV-2 infection
https://www.biorxiv.org/content/10.1101/2021.08.22.457114v1
The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines
https://www.medrxiv.org/content/10.1101/2021.08.19.21262307v1
Evolutionary dynamics of a virus in a vaccinated population
https://www.medrxiv.org/content/10.1101/2021.08.29.21262799v1
The emergence of SARS-CoV-2 variants of concern is driven by acceleration of the evolutionary rate
https://www.medrxiv.org/content/10.1101/2021.08.25.21262601v1
The resurgence risk of COVID-19 in the presence of immunity waning and ADE effect: a mathematical modelling study
https://www.biorxiv.org/content/10.1101/2021.08.10.455737v2
Spike mimicry of thrombopoietin may induce thrombocytopenia in COVID-19
https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1
SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database Analysis
https://www.biorxiv.org/content/10.1101/2021.09.06.459005v1
Ineffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera
https://www.medrxiv.org/content/10.1101/2021.09.03.21262934v1
Association Between SARS-CoV-2 RNAemia and Post-Acute Sequelae of COVID-19
https://www.biorxiv.org/content/10.1101/2021.06.01.446592v2
Multilocus adaptation to vaccination